skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Assessing suicidal risk with antiepileptic drugs

Review

(2076) Views  (523) Full article downloads

Authors: Marco Mula, Gail S Bell, Josemir W Sander

Published Date September 2010 Volume 2010:6(1) Pages 613 - 618
DOI: http://dx.doi.org/10.2147/NDT.S11999

Marco Mula2, Gail S Bell1, Josemir W Sander1,3
1Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, and National Hospital for Neurology and Neurosurgery, UCL Hospitals NHS Foundation Trust, London, United Kingdom; 2Department of Clinical and Experimental Medicine, Division of Neurology, Amedeo Avogadro University, University Hospital Maggiore della Carità, Novara, Italy; 3SEIN – Epilepsy Institute in the Netherlands Foundation, Heemstede, The Netherlands

Abstract: Recently, the US Food and Drug Administration issued an alert about an increased risk for suicidality during treatment with antiepileptic drugs (AEDs) for different indications, including epilepsy. We discuss the issue of suicide in epilepsy with special attention to AEDs and the assessment of suicide in people with epilepsy. It has been suggested that early medical treatment with AEDs might potentially reduce suicide risk of people with epilepsy, but it is of great importance that the choice of drug is tailored to the mental state of the patient. The issue of suicidality in epilepsy is likely to represent an example of how the underdiagnosis of psychiatric symptoms, the lack of input from professionals (eg, psychologists, social workers, and psychiatrists), and the delay in an optimized AED therapy may worsen the prognosis of the condition with the occurrence of severe complications such as suicide.

Keywords: epilepsy, suicide, adverse effect, depression






Readers of this article also read:

Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population
Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
Refinement of rigid-body protein–protein docking using backbone and side-chain minimization with a coarse-grained model
Health literacy and health seeking behavior among older men in a middle-income nation
ABO and rhesus blood group distribution in Kurds
Evaluation of glycopyrrolate in the treatment of chronic drooling
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Corrigendum
Corrigendum
Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?